Prostaglandin E2 and F2α inhibit growth of human gastric carcinoma cell line KATO III with simultaneous stimulation of cyclic AMP production
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 44 (1) , 75-80
- https://doi.org/10.1016/0024-3205(89)90220-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Biosynthetic pathways for the Leb and Y glycolipids in the gastric carcinoma cell line kato III as analyzed by a novel assayBiochemical and Biophysical Research Communications, 1988
- Gastrointestinal ulcer formation in rabbits immunized with prostaglandin E2Gastroenterology, 1987
- Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium.Journal of Clinical Investigation, 1983
- Growth inhibition of human breast cancer cells induced by calcitoninBiochemical and Biophysical Research Communications, 1983
- Prostaglandin generation from gastroduodenal mucosa: Regional and species differencesProstaglandins, 1982
- Urinary excretion of cyclic nucleotides and principal electrolytes in healthy humans of different agesClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugsBritish Journal of Cancer, 1980
- The effects of thromboxane B2 and 6-ketoprostaglandin F1α on cultured fibroblastsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1977
- Control of Deoxyribonucleic Acid Synthesis in Normal Rabbit Colonic MucosaGastroenterology, 1975
- Enhanced Effects of Prostaglandin E1 and Dibutyryl Cyclic AMP upon Human Lymphocytes in the Presence of CortisolJournal of Clinical Investigation, 1973